The frequency of complement deficiency in 176 of 7,732 patients with meningococcal disease in the Netherlands from 1959 through 1992 was assessed. Complement deficiency was found in six patients (3%): 3 (7%) of the patients with Neisseria meningitidis serogroup C disease, 1 (2%) of the patients with N. meningitidis serogroup A disease, and 2 (33%) of the patients with infections due to uncommon serogroups and nongroupable strains of N. meningitidis. Of 91 additional patients with meningococcal infections due to uncommon serogroups, 33% also had complement deficiency. Thirty-four of the 36 complement-deficient patients with meningococcal disease who were from 33 families were 5 years of age or older. Twenty-six additional complement-deficient relatives were found. Screening individuals with meningococcal disease due to uncommon serogroups who were 5 years of age or older identified 30 of the 33 complement-deficient families. Only 27% of the complement-deficient relatives had had meningococcal disease. This risk was lower for relatives with properdin deficiency (18%) than for those deficient in the late component of complement (38%). Therefore, pedigree studies are warranted for identifying those complement-deficient persons who require vaccination for meningococcal disease.
Pedigree Studies of Patients with Complement Deficiency
formed studies involving the relatives of complement-deficient probands. Pedigree studies were performed for patients with inherited complement deficiencies. In properdin-deficient families, presumed female carriers and their male offspring were requested Study Population and Methods to take part in the study. In families with other deficiencies, brothers, sisters, and parents of each proband were requested
Patients with Meningococcal Disease Selected for Complement
to participate in the study. Household members as well as other
Function Study
relatives of the patients were asked by questionnaire whether they had had meningococcal disease; if their answers reflected The archives of the Netherlands Reference Laboratory for a history of meningococcal disease, then a search in the arBacterial Meningitis have data on and CSF and blood isolates chives of the Netherlands Reference Laboratory for Bacterial from 7,732 patients (table 1) with meningococcal disease that Meningitis was done to collect clinical and/or bacteriologic were collected from 1959 through 1992. The isolates were data. If their data were not present, the medical records of the serogrouped by means of Ouchterlony gel diffusion with use general practitioner or the hospital to which they had been of rabbit antisera to the capsular polysaccharides of serogroups admitted were studied. If the medical history of a relative sug-A, B, C, 29E, H, I, K, L, W135, X, Y, and Z [6, 11, 12] . gested that meningococcal disease had occurred, the sibship of For each year in the period from 1959 through 1992, four that relative was studied for complement deficiency. None of patients each with meningococcal disease due to serogroups the complement-deficient patients or relatives had been vacci-A, B, and C were selected. Two of them were younger than 5 nated for meningococcal disease before or during the study years of age and two were 5 years of age or older at the period. time that they contracted the disease. Since the frequency of meningococcal disease due to the uncommon serogroups W135, X, Y, Z, and 29E and to nongroupable meningococci
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is low (table 1), three patients for each 10-year interval were selected. In the years 1989 through 1992, the incidence of Standard criteria were used to ascertain the clinical diagnosis of meningococcal disease in patients and relatives [10, 13] . Menin-N. meningitidis serogroup B disease increased twofold. Therefore, 55 additional patients with meningococcal disease due to gococcal disease was classified as meningitis, septicemia, meningitis with septicemia, and septic shock. Meningitis was defined serogroup B in this period were included.
The first study group included 460 (6%) of the 7,732 patients by a CSF culture positive for N. meningitidis or, in the case of a negative culture, by the presence of gram-negative diplococci in on the basis of age and infecting meningococcal serogroup. One hundred seventy-six patients (38%) were traceable and CSF sediment. In cases in which results of CSF culture or staining were not available, meningitis was defined on the basis of presence willing to participate in the study. The second study group included 91 of the other 225 patients with meningococcal disof symptoms and signs such as fever, headache, vomiting, and nuchal rigidity as well as an increased number of polymorphonuease due to uncommon serogroups in the period 1959 through 1992 who were traced and willing to participate in the study clear neutrophils, an increased protein concentration, and a decreased glucose concentration in the CSF. Meningococcal septice-( lected at the Netherlands Reference Laboratory for Bacterial Data for the patients were obtained from the archives of the Meningitis were characterized. Serogroups A, B, and C acNetherlands Reference Laboratory for Bacterial Meningitis and counted for 8%, 71%, and 18% of all strains, respectively. from the general practitioners and medical specialists in the Nongroupable meningococci and uncommon serogroups hospitals to which the patients had been admitted. In a previous (W135, X, Y, and Z) represented 3% of all patient isolates. study, data on 429 cases of meningococcal disease, which ocIn the first study group, 176 (38%) of the 460 patients took curred from 1989 through 1990, were collected and analyzed part in the study. Of these 176 patients, six (3%) had a complesimilarly to those for complement-deficient individuals [14] . ment deficiency (table 2) . One (2%) of the 45 patients with serogroup A disease and three (7%) of the 46 patients with serogroup C disease had a complement deficiency. Comple-
Assays for Complement Determination
ment deficiencies were not found in the 79 patients with meningococcal disease due to serogroup B. A complement deficiency All selected patients who were traced were visited by one was found in two (33%) of the six patients with meningococcal of us for collection of blood samples for complement studies.
disease due to the uncommon serogroups W135, X, Y, Z, and Serum samples were flash frozen and stored at 070ЊC. In cases 29E and nongroupable meningococci. In the second study in which a complement deficiency was assessed, blood samples group of an additional 91 patients with disease due to uncomfrom relatives were also collected for complement studies. Hemon serogroups, 30 (33%) had a complement deficiency. molytic screening for the alternative, classic, and terminal pathOf all 267 patients in both study groups, 92 (34%) were ways of complement activation was performed, both in gel younger than 5 years of age at the time of their disease. A according to Truedsson et al. [15] and in free suspension accomplement deficiency was present in only two (2%) of these cording to Nilsson and Nilsson [16] . Tests were done in duplipatients, while 34 (19%) of the 175 persons 5 years of age or cate. Control sera with a deficiency in the alternative pathway older at the time of their disease were complement-deficient (factor B; C-0535, Sigma, St. Louis) or the classic pathway (x 2 Å 15.79; P Å .0001). The age distribution for the 32 (C1q; 0410, Sigma) were always included.
complement-deficient patients with meningococcal disease due If hemolytic screening showed a defect in one of the pathto uncommon serogroups showed that only one (3%) was ways, the deficient component was identified by using quantitayounger than 5 years of age (figure 1). In contrast, 29 (45%) tive assays. ELISA was used for properdin, C8, and C9, and of the 65 complement-sufficient persons with meningococcal double radial immune diffusion assays were used for C3, factor disease due to uncommon serogroups were younger than 5 H, and factor B. Hemolytic assays were used for C3, C5, C6, years of age. Three of the four complement-deficient persons C7, factor D, and C3 nephritic factor (C3 NeF) [17, 18] . C8b with meningococcal disease due to serogroups A and C were deficiency was confirmed by western blotting [19] . Serum samalso 5 years of age or older. ples from the probands were studied for all factors within the affected pathway. Serum samples from relatives were quantitatively investigated for the particular complement component Properdin deficiency was the single most common complement deficiency; it was detected in 13 patients (36%) (table 2), of Statistical Analyses whom two had dysfunctional properdin. Properdin deficiency was identified only in patients with meningococcal disease due to The x 2 test or Fisher's exact test was used to determine whether the difference between the frequency of complement uncommon serogroups (table 2) . The mean age for these patients at the time of their disease was 12 years (range, 1-21 years). C3 deficiency in patients with meningococcal disease who were 5 years of age or older and younger than 5 years of age; the deficiency syndrome was present in six patients (17%) (mean age, 21 years; range, 10-48 years), of whom three had an acquired frequency of distinct clinical presentations of meningococcal disease in patients with properdin deficiency, patients with complement deficiency due to C3 NeF. One patient had factor H deficiency, and two patients had inherited C3 deficiency. LCCD LCCD, and complement-normal persons; and the frequency of meningococcal disease in complement-deficient and comple-(C5 through C8) was present in 17 patients (47%) (mean age, 16 years; range, 4-36 years) during the first episode of meningococment-normal relatives was significant. The proband method of Weinberg was used to assess the frequency of meningococcal cal disease. Patients with C3 deficiency syndrome and LCCD were found within all serogroups. disease in the complement-deficient families [20] .
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H -deficient (table 3) . Two C3-deficient relatives were found in one of two families. In the 15 families of patients with Studies involving 216 relatives of 27 families were done.
LCCD, 97 relatives (including 44 brothers and sisters of the There were 36 complement-deficient patients with meningoprobands) were studied. In nine (20%) of these 44 close relacoccal disease from 33 families. One patient with functional tives, a deficiency was detected. properdin deficiency, one patient with complete properdin deficiency, and one C8b-deficient patient belonged to families who were identified twice. Six families of six patients did not
Frequency of Meningococcal Disease in Relatives
participate in the study. Of the 216 relatives studied, 26 (12%) had a complement deficiency (table 3) .
Seven (27%) of the 26 complement-deficient relatives had had one or more episodes of meningococcal disease (table The nine families of the probands with complete properdin deficiency included 84 relatives, 34 of whom were males (17 3), while two of 190 complement-sufficient relatives had had meningococcal disease (P õ .01, Fisher's exact test). Meningowere descendants of obligate female carriers). Of these 17 males, 11 (65%) were properdin-deficient (table 3) . None of coccal disease occurred in two (18%) of 11 relatives with complete properdin deficiency at the ages of 1 year and 2 years, the 21 relatives of the factor H -deficient proband was factor 
Episodes of Recurrent Meningococcal Disease in Probands and

respectively (table 4). The mean age for nine relatives with
Relatives properdin deficiency and no previous meningococcal disease was 34 years (range, 22 -60 years). Properdin-deficient persons and individuals with factor H Five (38%) of the 13 relatives with LCCD had had meningoor C3 NeF deficiency had no recurrences of meningococcal coccal disease (table 3) ; one had C5 deficiency, and four had disease. The two probands with inherited C3 deficiency had C8b deficiency. In these latter four patients (all of whom beone recurrence of meningococcal disease due to serogroups B longed to one family), eight episodes of meningococcal disease and C, respectively. In total, 17 recurrences of meningococcal occurred (table 4) in the period between 1938 and 1990. The disease occurred in nine of the 16 probands with LCCD and mean age at the first episode of meningococcal disease in the three of the five relatives with LCCD. Twelve (57%) of the five patients with LCCD was 13 years (range, 6 -25 years).
21 patients with LCCD had two episodes of meningococcal The mean age for the eight relatives with LCCD who did not disease; of these 12 patients, four (33%) had a third episode have meningococcal disease was 38 years (range, 27 -55 years) and of these four, one (25%) had a fourth episode of meningococcal disease. Of the 16 probands with LCCD, nine (56%) at the end of the study period. had had 13 recurrences. These recurrent episodes of meningomeningococcal meningitis. Two of them proved to be properdin-deficient. The third relative, the brother of an obligate fecoccal disease were caused by serogroup B in 1 case, serogroup C in 3 cases, and serogroup Z in 1 case. Seven isolates male carrier who was presumed to be properdin-deficient, died of bacterial meningitis. The estimated mortality rate among were not serogrouped, and in one case, recurrence of meningitis was caused by the Neisseria-related Moraxella osloensis properdin-deficient patients with meningococcal disease, including the nine probands, was 8% (one of 12). [11] . Of the five relatives with LCCD and meningococcal disease, three had had four recurrent episodes of meningococWe collected information from 180 subjects, encompassing three to four generations, from the families of 15 patients with cal disease (table 4) .
LCCD. Six relatives were found who had had meningococcal meningitis, of whom five were complement-deficient. One fe-
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male relative died of meningococcal disease due to serogroup A at the age of 39 years, but her complement status was unThe clinical entities of meningococcal disease in 11 properknown. If she were complement-deficient, the estimated mordin-deficient individuals (10 probands and one relative) were tality rate among patients with LCCD and meningococcal discompared with those in 17 persons with LCCD (14 probands ease, including the 15 probands, would be 5% (one of 21). and three relatives) and with those in 429 patients from the general population (table 5) . Meningococcal septic shock developed in three properdin-deficient patients (27%); septic Discussion shock was caused by serogroup W135 in two patients and A complement deficiency was found in six (3%) of 176 serogroup Y in one. Meningococcal septic shock developed in patients with meningococcal disease who were selected for the five patients with LCCD (23%); it was caused by serogroup B study on the basis of age and infecting serogroup (first study in 1 patient, serogroup C in 2 patients, and serogroup W135 group). The number of patients with disease due to serogroup in 2 patients. No difference was found in the clinical course B was underrepresented with regard to the frequency of disease of meningococcal disease in patients with LCCD and in the due to this serogroup in the general population. None of our first and recurrent episodes. Forty-nine (11%) of 429 episodes patients with disease due to serogroup B had a complement of meningococcal disease were septic shock, either with or deficiency, but two of the 10 recurrences of meningococcal without meningitis, in the 429 patients in the general populadisease in complement-deficient patients were due to serogroup tion, which was significantly lower (P Å .04) than eight (24%)
B. This finding is in agreement with previous reports that seroof 33 episodes in both the properdin-deficient individuals and group B is rarely associated with complement deficiency [21 -the patients with LCCD. Serogroup B was the predominant 23]. A complement deficiency was found in 7% of patients (75%) serogroup for the 429 patients, of whom 41% were with meningococcal disease due to serogroup C and in 2% of younger than 5 years of age at the time of disease. patients with disease due to serogroup A. The distribution of complement deficiencies in the endemic situation of meningo- patients with meningococcal disease due to the uncommon Probands and their relatives were interviewed by questionnaire to assess the number of relatives who died of complement serogroups W135, X, Y, and Z (second study group), 30 (33%) had a complement deficiency. In three studies reporting the deficiency -related meningococcal disease. We obtained information from 140 subjects, encompassing three to four generafrequency of complement deficiency in patients infected with uncommon serogroups [5, 7, 8] , this rate varied from 26% to tions, from the families of nine properdin-deficient probands. Within one family, three relatives were found who had had 50%.
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The results of our study also confirm that the age at which families of the patients with LCCD included 97 relatives; 20% of the brothers and sisters of the probands were complementmeningococcal disease is contracted is another important criterion for the decision to perform complement studies [5, 8] . In deficient (this rate is in agreement with the expected rate of 25% for an autosomal recessive trait). Of the 13 relatives with the Netherlands, 41% -52% of patients with meningococcal disease are younger than 5 years of age [11, 24] . In our study, LCCD, five (38%) developed meningococcal disease; when the probands were included, the frequency of meningococcal 31 (46%) of the 67 patients older than 5 years of age who had meningococcal disease had a complement deficiency, whereas disease increased to 71%, which is higher than the previously estimated risk of 57% [1] . only one (3%) of the 30 patients younger than 5 years of age at the time of disease due to uncommon serogroups had a During the 33-year study period, the mean annual incidence of meningococcal disease in the general population was Ç2 complement deficiency. Our findings indicate that, in the general population, protection against disease due to uncommon cases per 100,000 persons (table 1). The incidence for the properdin-deficient individuals and those with LCCD was 500 serogroups is present at the age of 5 years, while the risk for the disease due to these serogroups remains in complementand 1,200 cases per 100,000 persons, respectively. Consequently, the risk of contracting meningococcal disease in prodeficient persons.
Of the 36 complement-deficient persons, complete properdin perdin-deficient persons and persons with LCCD is 250 and 600 times higher than that in the general population, respectively. deficiency was present in 11 patients (30%); dysfunctional properdin deficiency, in 2 related persons (6%); C3 deficiency However, it cannot be excluded that in certain complementdeficient families additional risk factors for meningitis are pressyndrome, in 6 patients (17%); and LCCD, in 17 patients (47%). Remarkably, no deficiency of a component of the classic ent, as indicated by the finding that two complement-normal relatives of one family with LCCD developed meningococcal pathway of complement activation was found, although homozygous C2 deficiency is supposed to be the most commonly disease. It may be that the IgG Fcg receptor phenotype FcgRIIa R131R131/IIIb NA2NA2 comprises such a factor, since an inherited defect of the complement cascade (occurring in 0.009% to 0.01% of the normal Caucasian population) [1] . association between this phenotype and meningococcal disease has been recently reported [26, 27] . In our study, we were able to estimate by questionnaire that 8% of properdin-deficient persons and 5% of individuals with
The identification of complement deficiency by testing for complement function in patients with meningococcal disease LCCD died of their meningococcal disease. The case-fatality rate for meningococcal disease in the general population is due to uncommon serogroups or nongroupable strains who were 5 years of age or older resulted in the recognition of 30 5.2% -7.7% [14, 24] . When the surviving probands were excluded, the mortality rate among properdin-deficient relatives (91%) of 33 complement-deficient families. In addition, two C3-deficient relatives, 11 relatives with complete properdin with meningococcal disease was 33% (one of three) and that among relatives with LCCD and meningococcal disease was deficiency, and 13 relatives with LCCD were identified by pedigree studies. Nine (82%) of 11 properdin-deficient relatives 17% (one of six). These high mortality rates among the small number of complement-deficient relatives were associated with and eight (62%) of 13 relatives with LCCD had not developed meningococcal disease. These relatives were all older than 20 a rather high frequency of meningococcal septic shock. However, it should be emphasized that only survivors underwent years of age, at which time it is assumed that 95% of the general population has had carriage of meningococci [28, 29] . complement screening. Therefore, the mortality rates associated with various complement deficiencies that have been reThe median age at which the probands and relatives developed meningococcal disease was 16 years. As a consequence of the ported may be negatively biased.
The risk of contracting meningococcal disease in persons usual approach of assessing complement deficiency in patients with meningococcal disease, a relevant number of complementwith the various types of complement deficiency differs considerably and is significantly higher than that in the general popudeficient individuals will not be detected. Therefore, pedigree studies are necessary to identify those complement-deficient lation. The families of the nine probands with total properdin deficiency included 84 relatives, 34 of whom were male (17 individuals who are candidates for vaccination for meningococcal disease. were descendants of obligate female carriers); of these 17 males, 65% had a properdin deficiency, which is close to the expected rate of 50% for an X-linked trait. Meningococcal
